Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
669
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines

Ali Azizia Laboratory Research and Innovations, CEPI, Washington, DC, USACorrespondence[email protected]
View further author information
,
Gathoni Kamuyub Laboratory Research and Innovations, CEPI, London, UKView further author information
,
Deborah Ogbenib Laboratory Research and Innovations, CEPI, London, UKView further author information
,
Philipa Levesque-Damphoussec Nexelis-Q2 Solutions, Laval, CanadaView further author information
,
Daniel Knottd UK Health Security Agency, Salisbury, UKView further author information
,
Luc Gagnonc Nexelis-Q2 Solutions, Laval, CanadaView further author information
,
Steven Phay-Tranc Nexelis-Q2 Solutions, Laval, CanadaView further author information
,
Bethan Husseyd UK Health Security Agency, Salisbury, UKView further author information
,
Pamela Proudd UK Health Security Agency, Salisbury, UKView further author information
,
Sue Charltond UK Health Security Agency, Salisbury, UKView further author information
,
Carolyn Clarka Laboratory Research and Innovations, CEPI, Washington, DC, USAView further author information
&
Valentina Bernasconie Laboratory Research and Innovations, CEPI, Oslo, NorwayView further author information
 show all
Article: 2344249 | Received 28 Mar 2024, Accepted 14 Apr 2024, Published online: 06 May 2024

References

  • Kumar A, Bernasconi V, Manak M, de Almeida Aranha AP, Kristiansen PA. The CEPI centralised laboratory network: supporting COVID-19 vaccine development. Lancet. 2021;397(10290):2148–3. doi:10.1016/S0140-6736(21)00982-X.
  • Manak M, Gagnon L, Phay-Tran S, Levesque-Damphousse P, Fabie A, Daugan M, Khan ST, Proud P, Hussey B, Knott D. et al. Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis. Lancet Microbe. 2024;5(3):216–25. doi:10.1016/S2666-5247(23)00324-5.
  • Azizi A, Manak M, Bernasconi V. The CEPI centralized laboratory network for COVID-19 will help prepare for future outbreaks. Nat Med. 2023;29(11):2684–5. doi:10.1038/s41591-023-02534-x.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.